BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28366868)

  • 1. Recent advances in the study of 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2)Inhibitors.
    Zhou C; Ye F; Wu H; Ye H; Chen Q
    Environ Toxicol Pharmacol; 2017 Jun; 52():47-53. PubMed ID: 28366868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2.
    Ma X; Lian QQ; Dong Q; Ge RS
    Toxicology; 2011 Jul; 285(3):83-9. PubMed ID: 21515335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
    Terao M; Itoi S; Murota H; Katayama I
    Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
    Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
    Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
    Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
    Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.
    Campino C; Carvajal CA; Cornejo J; San Martín B; Olivieri O; Guidi G; Faccini G; Pasini F; Sateler J; Baudrand R; Mosso L; Owen GI; Kalergis AM; Padilla O; Fardella CE
    Endocrine; 2010 Feb; 37(1):106-14. PubMed ID: 19882252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
    Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
    QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
    Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
    Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole.
    Beck KR; Bächler M; Vuorinen A; Wagner S; Akram M; Griesser U; Temml V; Klusonova P; Yamaguchi H; Schuster D; Odermatt A
    Biochem Pharmacol; 2017 Apr; 130():93-103. PubMed ID: 28131847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts.
    Sun K; Yang K; Challis JR
    Biol Reprod; 1998 Jun; 58(6):1379-84. PubMed ID: 9623596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2.
    Odermatt A; Arnold P; Frey FJ
    J Biol Chem; 2001 Jul; 276(30):28484-92. PubMed ID: 11350956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.